Priyanka Agarwal MD, MBA.
HealthEx
Priyanka Agarwal, MD, MBA is the co-founder and CEO of HealthEx. She is a physician with leadership experience across the academic medicine, biotech/pharma, and startup spaces. At UCSF, she was the physician leader for telemedicine and digital patient experience, and also an Associate Professor of Medicine in the Dept. of Medicine. She more recently led the digital health/AI program at MyoKardia, a precision medicine biotech acquired by Bristol Myers Squibb in 2020. In her work at MyoKardia and then Bristol Myers, she led the unit supporting the FDA approval and commercial adoption of AI Algorithms for